NEW YORK (
Spectrum Pharmaceuticals Inc
) is trading at unusually high volume Friday with 3.9 million shares changing hands. It is currently at 4.1 times its average daily volume and trading down 61 cents (-5.9%) at $9.75 as of 11:07 a.m. ET.
Spectrum has a market cap of $519 million and is part of the
industry. Shares are up 50.8% year to date as of the close of trading on Thursday.
Spectrum Pharmaceuticals, Inc. operates as a commercial-stage biotechnology company with a primary focus in oncology and hematology. The company engages in acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products.
TheStreet Ratings rates Spectrum as a
. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share. You can view the full
See all heavy volume stocks in our
or get investment ideas from our
Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from